Bio-Thera Solutions Ltd Capital Reinvestment Ratio

Latest as of December 2021: 0.07x

Bio-Thera Solutions Ltd capital reinvestment ratio. Bio-Thera Solutions Ltd (688177) has a Capital Reinvestment Ratio of 0.07x as of December 2021, meaning it reinvests 0% of its operating cash flow (CN¥368.97 Million) in capital expenditures (CN¥26.25 Million). Check Bio-Thera Solutions Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.07x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥368.97 Million
CNY

Capital Expenditures

CN¥26.25 Million
CNY

Data as of

Dec 2021
Most recent filing

Capital Reinvestment Ratio of Bio-Thera Solutions Ltd (2021–2021)

Capital reinvestment ratio of Bio-Thera Solutions Ltd from 2021 to 2021. This chart tracks Bio-Thera Solutions Ltd's Capital Reinvestment Ratio across 1 annual periods. Also explore Bio-Thera Solutions Ltd net asset momentum to track the company's year-over-year net asset growth rate.

Bio-Thera Solutions Ltd Capital Reinvestment Ratio by Year (2021–2021)

Bio-Thera Solutions Ltd capital reinvestment ratio by year from 2021 to 2021. For the full cash flow conversion analysis, see cash efficiency ratio of Bio-Thera Solutions Ltd.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2021 0.33x CN¥236.27 Million CN¥77.89 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow